A Multinational Vaccine Company Reduces Footprint and Cost with Pall Resolute® Linear AutoPak Chromatography Columns (Case Study)

David Johnson, Global Product Manager
david_m._johnson@pall.com
http://www.pall.com/main/biopharmaceuticals/product.page?lid=hrch8nf8

Reduced packing success rate caused by operator error or a shortage of experienced operators is a major risk to the successful completion of the packing, unpacking and cleaning of process-scale chromatography columns. Coupled with expensive media wastage from traditional packing methods that require an excess in the slurry tank, it is obvious that a solution is sorely needed to address the challenges around downstream column chromatography.

A Multinational Vaccine Company Reduces Footprint and Cost with Pall Resolute® Linear AutoPak Chromatography Columns (Case Study)Pall worked with a multinational vaccine company to develop a solution to these issues; previously reliant on paper-SOP-driven packing for its global operations, the company realized that large savings could be achieved both in time and money through the automation of column packing. Using the Pall AutoPak solution, the company moved to fully automated packing and it projects increases in the packing success rate from 62% to 99%, combined with a reduction in labor costs for packing and unpacking operations of 31% in one site, and 41% in another site.

Maintenance and cleaning costs are also lowered because there are no extra pumps or packing skids required. And because the new columns have a smaller cleanroom/storage footprint, they deliver more space in tight cleanrooms.

The adoption of this technology as a global platform also ensures a consistent geographical approach, making tech transfer much easier.

This new generation of automated packing systems provides automated sequences that ensure reliable and consistent operation. The fully automated approach enables packing to be accomplished by any operator, thus eliminating error and reducing the dependence on key operators. In addition, the ability to use all of the slurry in the tank means savings can be achieved in overall sorbent consumption. In terms of equipment safety, the added benefit of multi-axis piston movement delivers monitoring and control functionality that is missing in single-actuator designs. All in all, the new generation of automated packing systems can enable biopharmaceutical manufacturers to produce a higher-quality product at a lower cost.

To learn more, please visit: http://www.pall.com/main/biopharmaceuticals/product.page?lid=hzpx43t5


INTERPHEX

Learn more about the single source for complete biopharmaceutical manufacturing solutions that gathers 12,000 industry professionals each year.

Posted in Uncategorized | Tagged , , | Leave a comment

Clinical Dosage Form Development or an Early Approach to Achieve Peak Sales

Courtesy of Somma Tech Consulting Company

Clinical Dosage Form Development or an Early Approach to Achieve Peak Sales Step #1

Pharmaceutical Development continues to present many fundamental challenges when dealing with promising drug lead opportunities. This is a factor across all therapeutic areas from Central Nervous System (CNS) to oncology. In an effort to design new molecular entities which are increasingly effective while minimizing unwanted side effects we at times create drug compounds which are poorly soluble or are unstable and difficult to handle during manufacture.  Continue reading

Posted in Uncategorized | Tagged , , | Leave a comment

Washing Systems

Courtesy of Cozzoli Machine Company

The importance of a reliable vial and ampule cleaning system cannot be overstated. Having a supplier that can offer a complete product line of equipment that includes washing machinery plus service and maintenance is essential. Continue reading

Posted in Uncategorized | Tagged , , , | Leave a comment

Fluid Bed Technology

Courtesy of L.B. Bohle

Fluid bed equipment has been established in the pharmaceutical industry for more than 50 years. Today, fluid bed drying can still be considered state of the art within pharmaceutical processes. Continue reading

Posted in Uncategorized | Tagged , , | Leave a comment

3D Printing in Pharm – Packaging, Prototyping and Pills?

Courtesy of Pharmaceutical Processing
by Jeff Reinke, Editorial Director, Pharmaceutical Processing

While many of the conversations in the recently concluded INTERPHEX exhibition hall surrounded more mature, but increasing significant production technologies like single-use equipment and serialization management, there was one newcomer that definitely stood out. Amongst the educational sessions and product unveilings was a new pavilion dedicated to 3D printing. Continue reading

Posted in Uncategorized | Leave a comment

The New VHP LTS-V Process is the Key to the Increasing Demand of Surfaces Terminal Sterilization in the Production of Temperature or Radiation Sensitive Drug Delivery Device Products

As the result of developing new biological drugs and following their success, there is an increasing need for low temperature terminal surface sterilization of delivery devices with sensitive biological products or other drug products with sensitive ingredients. Continue reading

Posted in Uncategorized | Tagged , , , , | Leave a comment

Designing for Potent Compound Exposure Levels – Not as Easy as 1-2-3

By Paul Valerio, Director, Technology – IPS

Categorizing things is a method people use to survive.  Searching the internet on this topic yields many interesting studies and theories about why we do it.  Categorization helps us to identify a situation quickly, categorize it and act accordingly.  We do it all the time. Continue reading

Posted in Uncategorized | Tagged , , | Leave a comment